Leptin tA PEG

Alternative Names: Not Available

Recombinant Human Leptin Triple Antagonist, Pegylated is a bioengineered protein that acts as an antagonist to the hormone leptin, which regulates appetite and energy expenditure. Belonging to the family of pegylated proteins, this therapeutic agent is designed to modulate leptin signaling pathways and potentially aid in the management of obesity and related metabolic disorders. With a weight of approximately [insert weight], this pegylated antagonist exhibits enhanced stability and prolonged circulation in the body, allowing for sustained therapeutic effects. Its mechanism of action offers a promising avenue for research and potential treatment options in the field of obesity management.

Skip to product information
  • Sku: PSB-cyt-702-5µg
  • Vendor: ProSpec-Tany
$60.00 USD
 per 
Shipping calculated at checkout.

Contact us directly for international purchases.

Title

Product Details

Product Description

Recombinant Human Leptin Triple Antagonist, Pegylated is a bioengineered protein that acts as an antagonist to the hormone leptin, which regulates appetite and energy expenditure. Belonging to the family of pegylated proteins, this therapeutic agent is designed to modulate leptin signaling pathways and potentially aid in the management of obesity and related metabolic disorders. With a weight of approximately [insert weight], this pegylated antagonist exhibits enhanced stability and prolonged circulation in the body, allowing for sustained therapeutic effects. Its mechanism of action offers a promising avenue for research and potential treatment options in the field of obesity management.

Current Lead Time

7-14 Days

Product Specifications

Species
Human
Expression System E. coli
Purity 98% by SDS-PAGE
Activity
Capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its in vitro activity is 6-8 fold lower than the non-pegylated antagonist but in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. Its in vivo activity compared to that of PEG-MLA is 9-27 fold higher. Capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its in vitro activity is 6-8 fold lower than the non-pegylated antagonist but in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. Its in vivo activity compared to that of PEG-MLA is 9-27 fold higher.
Activity Assay
Animal Component Free (ACF) Yes
Molecular Weight
N/A
Structure Contact for Details
Endotoxin Concentration
Not Available
Purification Method Not Available
Form
Lyophilized
Formulation The protein was lyophilized from a concentrated (0.65mg/ml) solution with 0.003mM NaHCO3.

*For Research Use Only

Product Guarantee

If your product is within its expiration period, and has not performed according to expectations, fill out the sample return form. Return the unused sample frozen, with the auto generated packing slip to the address on the instructions. You will receive a full refund along with a replacement of the unused portion (inclusive of the failed test). Damages do not cover any additional costs incurred for failed experimentation. 

Storage Instruction

Lyophilized PEG-SHLA although stable at room temperature for several weeks, should be stored desiccated below - 20C. Upon reconstitution at > 0.1 mg/ml and up to 2 mg/ml of PEG-SHLA and filter sterilization mLEP mutant can be stored at 4C or even room temperature for several weeks making it suitable for long term infusion studies using osmotic pumps. At lower concentration addition of a carrier protein (0.1% HSA or BSA) is suggested. Please prevent freeze-thaw cycles.

Sample Prep Instruction

It is recommended to reconstitute the lyophilized Leptin Antagonist Triple Mutant pegylated Human Recombinant in sterile 0.4% NaHCO3 adjusted to pH 8-9, not less than 100µg/ml, which can then be further diluted to other aqueous solutions.

References

Not Available

View full details

Leptin tA PEG

SUBHEADING

Recently viewed products